Angela Yang joined the LGR as a GSK Investigator in September 2021. Angela specializes in epigenomic technologies (such as Hi-C-based methods) for studying genome-wide long-range chromatin interactions, as well as single-cell sequencing technologies including scRNA-seq and scATAC-seq. Angela has a broad interest in applying next-generation sequencing for functional genomics studies, particularly with the aim for understanding disease biology. At the LGR, Angela’s research will focus on the development and implementation of cutting edge single-cell sequencing methodologies that can be used to enable high-throughput functional studies with CRISPR-mediated perturbations.

‍